165 related articles for article (PubMed ID: 31094856)
21. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response.
Bani-Sadr F; Loko MA; Pambrun E; Winnock M; Carrieri P; Gilbert C; Duvivier C; Bouchaud O; Gervais A; Dabis F; Salmon D;
AIDS; 2014 May; 28(8):1155-60. PubMed ID: 24499953
[TBL] [Abstract][Full Text] [Related]
22. Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.
Yaya I; Roux P; Marcellin F; Wittkop L; Esterle L; Spire B; Dominguez S; Elegbe BA; Piroth L; Sogni P; Salmon-Ceron D; Carrieri MP;
PLoS One; 2018; 13(7):e0199874. PubMed ID: 29975764
[TBL] [Abstract][Full Text] [Related]
23. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).
Marcellin F; Di Beo V; Aumaitre H; Mora M; Wittkop L; Duvivier C; Protopopescu C; Lacombe K; Esterle L; Berenger C; Gilbert C; Bouchaud O; Poizot-Martin I; Sogni P; Salmon-Ceron D; Carrieri P;
J Hepatol; 2020 Mar; 72(3):588-591. PubMed ID: 31924411
[No Abstract] [Full Text] [Related]
24. Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)".
Evon DM; Sarkar S; Amador J; Lok AS; Sterling RK; Stewart PW; Reeve BB; Serper M; Reau N; Reddy KR; Di Bisceglie AM; Nelson DR; Golin CE; Lim JK; Fried MW
J Hepatol; 2020 Mar; 72(3):592-593. PubMed ID: 31889556
[No Abstract] [Full Text] [Related]
25. HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study).
Barré T; Mercié P; Marcellin F; Esterle L; Duvivier C; Teicher E; Bureau M; Chas J; Salmon-Céron D; Sogni P; Carrieri MP; Wittkop L; Protopopescu C;
AIDS Behav; 2021 Dec; 25(12):4141-4153. PubMed ID: 33903998
[TBL] [Abstract][Full Text] [Related]
26. Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, France, 2006-2008.
Michel L; Villes V; Dabis F; Spire B; Winnock M; Loko MA; Poizot-Martin I; Valantin MA; Bonnard P; Salmon-Céron D; Carrieri MP;
J Viral Hepat; 2010 Sep; 17(9):650-60. PubMed ID: 20002565
[TBL] [Abstract][Full Text] [Related]
27. Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
Shili-Masmoudi S; Sogni P; de Ledinghen V; Esterle L; Valantin MA; Poizot-Martin I; Simon A; Rosenthal E; Lacombe K; Pialoux G; Bouchaud O; Gervais-Hasenknoff A; Goujard C; Piroth L; Zucman D; Dominguez S; Raffi F; Alric L; Bani-Sadr F; Lascoux-Combe C; Garipuy D; Miailhes P; Vittecoq D; Duvivier C; Aumaître H; Neau D; Morlat P; Dabis F; Salmon D; Wittkop L;
PLoS One; 2019; 14(1):e0211286. PubMed ID: 30682180
[TBL] [Abstract][Full Text] [Related]
28. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.
Loko MA; Bani-Sadr F; Valantin MA; Lascoux-Combe C; Fontaine H; Bonnard P; Gervais A; Bouchaud O; Garipuy D; Quertainmont Y; Vittecoq D; Tehrani MS; Winnock M; Dabis F; Salmon D;
Antivir Ther; 2012; 17(7):1335-43. PubMed ID: 23052829
[TBL] [Abstract][Full Text] [Related]
29. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
[TBL] [Abstract][Full Text] [Related]
30. Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH).
Antwerpes S; Protopopescu C; Morlat P; Marcellin F; Wittkop L; Di Beo V; Salmon-Céron D; Sogni P; Michel L; Carrieri MP; The Anrs Co Hepavih Study Group
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32825538
[TBL] [Abstract][Full Text] [Related]
31. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician.
Roux P; Cohen J; Lascoux-Combe C; Sogni P; Winnock M; Salmon-Ceron D; Spire B; Dabis F; Carrieri MP;
Drug Alcohol Depend; 2011 Jul; 116(1-3):228-32. PubMed ID: 21239121
[TBL] [Abstract][Full Text] [Related]
32. Comparison of risk factors in HIV-infected men who have sex with men, coinfected or not with hepatitis C virus (ANRS VESPA2 French cross-sectional national survey).
Marcellin F; Lorente N; Demoulin B; Carrieri MP; Suzan-Monti M; Roux P; Lert F; Sagaon-Teyssier L; Dray-Spira R; Spire B;
Sex Transm Infect; 2015 Feb; 91(1):21-3. PubMed ID: 25096920
[TBL] [Abstract][Full Text] [Related]
33. Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort).
Marcellin F; Lions C; Winnock M; Salmon D; Durant J; Spire B; Mora M; Loko MA; Dabis F; Dominguez S; Roux P; Carrieri MP;
Addiction; 2013 Jul; 108(7):1250-8. PubMed ID: 23421419
[TBL] [Abstract][Full Text] [Related]
34. Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).
Carrieri P; Bourlière M; Di Beo V; Lusivika-Nzinga C; Ramier C; Antwerpes S; Protopopescu C; Lacombe JM; Pol S; Fontaine H; Mourad A; Carrat F; Duracinsky M; Marcellin F;
Qual Life Res; 2023 Dec; 32(12):3427-3438. PubMed ID: 37587323
[TBL] [Abstract][Full Text] [Related]
35. Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).
Marcellin F; Protopopescu C; Esterle L; Wittkop L; Piroth L; Aumaitre H; Bouchaud O; Goujard C; Vittecoq D; Dabis F; Salmon-Ceron D; Spire B; Roux P; Carrieri MP;
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):786-791. PubMed ID: 28418984
[TBL] [Abstract][Full Text] [Related]
36. Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals.
Shuper PA; Joharchi N; Irving H; Fletcher D; Kovacs C; Loutfy M; Walmsley SL; Wong DK; Rehm J
AIDS Care; 2016 Aug; 28(8):954-62. PubMed ID: 26971360
[TBL] [Abstract][Full Text] [Related]
37. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.
Billa O; Chalouni M; Salmon D; Poizot-Martin I; Gilbert C; Katlama C; Neau D; Chas J; Morlat P; Lacombe K; Naqvi A; Barange K; Gervais A; Bouchaud O; Rosenthal E; Lascoux-Combe C; Garipuy D; Alric L; Dominguez S; Vittecoq D; Goujard C; Duvivier C; Aumaitre H; Miailhes P; Zucman D; Simon A; Lazaro E; Raffi F; Esterle L; Wittkop L; Bani-Sadr F;
PLoS One; 2018; 13(12):e0208657. PubMed ID: 30562358
[TBL] [Abstract][Full Text] [Related]
39. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
[TBL] [Abstract][Full Text] [Related]
40. Retrospective study of hepatitis C outcomes and treatment in HIV co-infected persons from the Australian HIV Observational Database.
Puhr R; Wright ST; Hoy JF; Templeton DJ; Durier N; Matthews GV; Russell D; Law MG
Sex Health; 2017 Aug; 14(4):345-354. PubMed ID: 28482168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
